European big pharma unites amid ‘ringing alarm bells’ of continent's dominance

All the chairs of Europe’s big pharma companies have written a public letter asserting that a shift in strategy is needed to close the gap to international rivals. All the chairs of Europe’s big pharma companies have written a public letter asserting that a shift in strategy is needed to close the gap to international rivals. In an open letter to European governments, the chairs of AstraZeneca, Boehringer Ingelheim, Chiesi, Ipsen, GSK, Novo Nordisk, Novartis, Roche and Sanofi expressed concern. Credit: Vladimir Sukhachev/Shutterstock.com. The boardrooms of all European big pharma companies have issued a stark warning regarding the current competitiveness…

Source: Clinical Trials Arena